Leaf Expression Systems has announced that Richard Hart has joined the company as business development director.
With over thirty years of experience in the biopharma sector, Richard will play a major role in ensuring Leaf realizes the full value of its game-changing plant transient expression technology,
Hypertrans through establishing commercial collaborations in key markets and own pipeline development.
Richard has particularly strong knowledge of the biologics field, ranging from his most recent position as Global Business Development Director at Stelis Biopharma, through similar senior management roles at Syngene, Stratophase, Baxter Healthcare, Fujifilm Diosynth Biologics and CMC Biologics.
Leaf CEO Simon Saxby commented: “I am delighted to welcome Richard to the Leaf Expression Systems team at such an important time in the growth of the business. I have worked with him in the past and am certain that his skillset and experience will be invaluable as we aim to establish Leaf Expression Systems as a partner of choice by adding real value to the research and development programmes of our clients across the globe.”